Skip to main content
Top
Published in: Rheumatology International 11/2009

01-09-2009 | Case Report

Fatal myocarditis in adult-onset Still disease with diffuse intravascular coagulation

Authors: Matteo Colina, Marcello Govoni, Francesco Trotta

Published in: Rheumatology International | Issue 11/2009

Login to get access

Abstract

Adult-onset Still disease (AOSD) is a rare condition disease of unknown etiology, characterized by quotidian or double quotidian spiking fever, with an evanescent pink-salmon rash, arthritis and multi-organ involvement. Diagnosis is usually clinical and made after other diseases in the differential diagnosis are excluded. We herein report the case of a patient with a remarkable familial autoimmune background in whom adult Still disease started off with a diffuse intravascular coagulation, probably triggered by a macrophage activation syndrome, followed by an acute interstitial myocarditis, leading to a fatal complete atrioventricular block. This case highlights that AOSD represents a troubling condition and that it may suddenly get worse with life-threatening events.
Literature
1.
go back to reference Yamaguchi M, Ohta A, Tsunematsu T et al (1992) Preliminary criteria for classification of adult Still’s disease. J Rheumatol 19:424–430PubMed Yamaguchi M, Ohta A, Tsunematsu T et al (1992) Preliminary criteria for classification of adult Still’s disease. J Rheumatol 19:424–430PubMed
2.
go back to reference Wouters JM, van de Putte LB (1986) Adult-onset Still’s disease: clinical and laboratory features, treatment and progress of 45 cases. Q J Med 61:1055–1065PubMed Wouters JM, van de Putte LB (1986) Adult-onset Still’s disease: clinical and laboratory features, treatment and progress of 45 cases. Q J Med 61:1055–1065PubMed
4.
go back to reference Masson C, Le Loet X, Liote F et al (1995) Adult Still’s disease: part I. Manifestations and complications in sixty-five cases in France. Rev Rhum Engl Ed 62:748–757PubMed Masson C, Le Loet X, Liote F et al (1995) Adult Still’s disease: part I. Manifestations and complications in sixty-five cases in France. Rev Rhum Engl Ed 62:748–757PubMed
5.
6.
go back to reference Esumi N, Ikushima S, Hibi S et al (1988) High serum ferritin level as a marker of malignant histiocytosis and virus-associated hemophagocytic syndrome. Cancer 61:2071–2076. doi:10.1002/1097-0142(19880515)61:10<2071::AID-NCR2820611023>3.0.CO;2-6PubMedCrossRef Esumi N, Ikushima S, Hibi S et al (1988) High serum ferritin level as a marker of malignant histiocytosis and virus-associated hemophagocytic syndrome. Cancer 61:2071–2076. doi:10.1002/1097-0142(19880515)61:10<2071::AID-NCR2820611023>3.0.CO;2-6PubMedCrossRef
10.
go back to reference Vandergheynst F, Gosset J, van de Borne P et al (2005) Myopericarditis revealing adult-onset Still’s disease. Acta Clin Belg 60:205–208PubMed Vandergheynst F, Gosset J, van de Borne P et al (2005) Myopericarditis revealing adult-onset Still’s disease. Acta Clin Belg 60:205–208PubMed
12.
13.
go back to reference Yang DH, Chang DM, Lai JH et al (2008) Etanercept as a rescue agent in patient with adult onset Still’s disease complicated with congestive heart failure. Rheumatol Int 29(1):95–98PubMedCrossRef Yang DH, Chang DM, Lai JH et al (2008) Etanercept as a rescue agent in patient with adult onset Still’s disease complicated with congestive heart failure. Rheumatol Int 29(1):95–98PubMedCrossRef
14.
go back to reference Prieur AM (1996) Intravenous immunoglobulins in Still’s disease: still controversial, still unproven. J Rheumatol 23:797–800PubMed Prieur AM (1996) Intravenous immunoglobulins in Still’s disease: still controversial, still unproven. J Rheumatol 23:797–800PubMed
16.
go back to reference Lequerré T, Quartier P, Rosellini D et al (2008) Interleukin-1 receptor antagonist (anakinra) treatment in patient with systemic-onset juvenile idiopathic arthritis or adult-onset Still disease: preliminary experience in France. Ann Rheum Dis 67:302–308. doi:10.1136/ard.2007.076034 PubMedCrossRef Lequerré T, Quartier P, Rosellini D et al (2008) Interleukin-1 receptor antagonist (anakinra) treatment in patient with systemic-onset juvenile idiopathic arthritis or adult-onset Still disease: preliminary experience in France. Ann Rheum Dis 67:302–308. doi:10.​1136/​ard.​2007.​076034 PubMedCrossRef
17.
go back to reference Quartuccio L, De Vita S (2007) Interleukin 1 receptor antagonist therapy-induced thrombocytopenia in adult onset Still’s disease. J Rheumatol 34:892–893PubMed Quartuccio L, De Vita S (2007) Interleukin 1 receptor antagonist therapy-induced thrombocytopenia in adult onset Still’s disease. J Rheumatol 34:892–893PubMed
Metadata
Title
Fatal myocarditis in adult-onset Still disease with diffuse intravascular coagulation
Authors
Matteo Colina
Marcello Govoni
Francesco Trotta
Publication date
01-09-2009
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 11/2009
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-008-0813-3

Other articles of this Issue 11/2009

Rheumatology International 11/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.